The outlook of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key regions has introduced substantial uncertainty . Investors are now facing the consequences of generic competition , r